{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:58:13Z","timestamp":1790434693286,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31870159"],"award-info":[{"award-number":["31870159"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI140063"],"award-info":[{"award-number":["AI140063"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI116813"],"award-info":[{"award-number":["AI116813"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.coi.2019.02.001","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T20:48:41Z","timestamp":1552682921000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Antigenic cross-reactivity between Zika and dengue viruses: is it time to develop a universal vaccine?"],"prefix":"10.1016","volume":"59","author":[{"given":"Jinsheng","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujan","family":"Shresta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2019.02.001_bib0005","series-title":"Rapid Risk Assessment: Zika Virus Infection Outbreak","author":"Control ECfDPa","year":"2014"},{"key":"10.1016\/j.coi.2019.02.001_bib0010","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.3201\/eid2110.150847","article-title":"Zika virus outbreak, Bahia, Brazil","volume":"21","author":"Campos","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.coi.2019.02.001_bib0015","series-title":"Zika Situation Report: Zika Virus, Microcephaly and Guillain-Barre Syndrome","first-page":"1","author":"WHO","year":"2017"},{"key":"10.1016\/j.coi.2019.02.001_bib0020","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1128\/CMR.11.3.480","article-title":"Dengue and dengue hemorrhagic fever","volume":"11","author":"Gubler","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.coi.2019.02.001_bib0025","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.coi.2019.02.001_bib0030","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4103\/0972-9062.197260","article-title":"Zika virus infection: past and present of another emerging vector-borne disease","volume":"53","author":"Sakkas","year":"2016","journal-title":"J Vector Borne Dis"},{"key":"10.1016\/j.coi.2019.02.001_bib0035","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0140-6736(16)00006-4","article-title":"Zika virus in Brazil and macular atrophy in a child with microcephaly","volume":"387","author":"Ventura","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2019.02.001_bib0040","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.autrev.2017.10.008","article-title":"Zika virus and autoimmunity. One-step forward","volume":"16","author":"Monsalve","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.coi.2019.02.001_bib0045","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev-immunol-042617-053142","article-title":"Immune response to dengue and Zika","volume":"36","author":"Ngono","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.coi.2019.02.001_bib0050","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.celrep.2016.07.049","article-title":"Broadly neutralizing activity of Zika virus-immune sera identifies a single viral serotype","volume":"16","author":"Dowd","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.coi.2019.02.001_bib0055","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-med-040717-051127","article-title":"Zika virus vaccine development: progress in the face of new challenges","volume":"70","author":"Diamond","year":"2018","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.coi.2019.02.001_bib0060","doi-asserted-by":"crossref","first-page":"E2046","DOI":"10.1073\/pnas.1305227110","article-title":"Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells","volume":"110","author":"Weiskopf","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2019.02.001_bib0065","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1128\/JVI.02892-15","article-title":"Immunodominant dengue virus-specific CD8+ T cell responses are associated with a memory PD-1+ phenotype","volume":"90","author":"de Alwis","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2019.02.001_bib0070","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.4049\/jimmunol.1101970","article-title":"Insights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine design","volume":"187","author":"Weiskopf","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2019.02.001_bib0075","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.4049\/jimmunol.0801974","article-title":"A protective role for dengue virus-specific CD8+ T cells","volume":"182","author":"Yauch","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2019.02.001_bib0080","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01309","article-title":"Global assessment of dengue virus-specific CD4(+) T cell responses in dengue-endemic areas","volume":"8","author":"Grifoni","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2019.02.001_bib0085","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/infdis\/jiw309","article-title":"HLA-DRB1 alleles are associated with different magnitudes of dengue virus-specific CD4+ T-cell responses","volume":"214","author":"Weiskopf","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2019.02.001_bib0090","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1128\/JVI.02675-12","article-title":"Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection","volume":"87","author":"Rivino","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2019.02.001_bib0095","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02147-16","article-title":"Human CD4(+) T cell responses to an attenuated tetravalent dengue vaccine parallel those induced by natural infection in magnitude, HLA restriction, and antigen specificity","volume":"91","author":"Angelo","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2019.02.001_bib0100","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02133-16","article-title":"Patterns of cellular immunity associated with experimental infection with rDEN2Delta30 (Tonga\/74) support its suitability as a human dengue virus challenge strain","volume":"91","author":"Grifoni","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2019.02.001_bib0105","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.4049\/jimmunol.1001709","article-title":"CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination","volume":"185","author":"Yauch","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2019.02.001_bib0110","doi-asserted-by":"crossref","DOI":"10.3390\/v10090480","article-title":"Improved immune responses against Zika virus after sequential dengue and Zika virus infection in humans","volume":"10","author":"Delgado","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.coi.2019.02.001_sbref0115","doi-asserted-by":"crossref","DOI":"10.1038\/nmicrobiol.2017.36","article-title":"Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8+ T cells","volume":"2","author":"Wen","year":"2017","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.coi.2019.02.001_bib0120","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41598-017-18781-1","article-title":"T cell immunity to Zika virus targets immunodominant epitopes that show cross-reactivity with other flaviviruses","volume":"8","author":"Reynolds","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2019.02.001_bib0125","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3389\/fimmu.2018.01196","article-title":"Structural influence on the dominance of virus-specific CD4 T cell epitopes in Zika virus infection","volume":"9","author":"Koblischke","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2019.02.001_sbref0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.chom.2016.12.010","article-title":"Mapping and role of the CD8+ T cell response during primary Zika virus infection in mice","volume":"21","author":"Elong Ngono","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coi.2019.02.001_bib0135","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(07)61687-0","article-title":"Dengue","volume":"370","author":"Halstead","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2019.02.001_bib0140","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.chom.2010.01.004","article-title":"Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease","volume":"7","author":"Zellweger","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coi.2019.02.001_bib0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000790","article-title":"Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification","volume":"6","author":"Balsitis","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coi.2019.02.001_sbref0150","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.aan6836","article-title":"Antibody-dependent enhancement of severe dengue disease in humans","volume":"358","author":"Katzelnick","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.coi.2019.02.001_bib0155","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41586-018-0157-4","article-title":"Reconstruction of antibody dynamics and infection histories to evaluate dengue risk","volume":"557","author":"Salje","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.coi.2019.02.001_sbref0160","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of dengue serostatus on dengue vaccine safety and efficacy","volume":"379","author":"Sridhar","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2019.02.001_bib0165","doi-asserted-by":"crossref","first-page":"7852","DOI":"10.1073\/pnas.1607931113","article-title":"Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus","volume":"113","author":"Priyamvada","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2019.02.001_bib0170","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.aaf8505","article-title":"Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection","volume":"353","author":"Stettler","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.coi.2019.02.001_bib0175","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/ni.3515","article-title":"Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with Zika virus","volume":"17","author":"Dejnirattisai","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2019.02.001_bib0180","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01123-16","article-title":"Dengue virus envelope dimer epitope monoclonal antibodies isolated from dengue patients are protective against Zika virus","volume":"7","author":"Swanstrom","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.coi.2019.02.001_bib0185","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nature18938","article-title":"Structural basis of potent Zika-dengue virus antibody cross-neutralization","volume":"536","author":"Barba-Spaeth","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.coi.2019.02.001_bib0190","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13679","article-title":"Neutralization mechanism of a highly potent antibody against Zika virus","volume":"7","author":"Zhang","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2019.02.001_bib0195","article-title":"Utility of a dengue-derived monoclonal antibody to enhance Zika infection in vitro","volume":"8","author":"Charles","year":"2016","journal-title":"PLoS Curr"},{"key":"10.1016\/j.coi.2019.02.001_sbref0200","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1126\/science.aal4365","article-title":"Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity","volume":"356","author":"Bardina","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.coi.2019.02.001_bib0205","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/s41591-018-0056-0","article-title":"Therapeutic and protective efficacy of a dengue antibody against Zika infection in rhesus monkeys","volume":"24","author":"Abbink","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2019.02.001_bib0210","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/ni.3849","article-title":"Human antibodies to the dengue virus E-dimer epitope have therapeutic activity against Zika virus infection","volume":"18","author":"Fernandez","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2019.02.001_bib0215","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.chom.2018.10.008","article-title":"Cross-reactive dengue virus antibodies augment Zika virus infection of human placental macrophages","volume":"24","author":"Zimmerman","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coi.2019.02.001_bib0220","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.chom.2018.09.015","article-title":"Maternally acquired Zika antibodies enhance dengue disease severity in mice","volume":"24","author":"Fowler","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coi.2019.02.001_bib0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006487","article-title":"Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques","volume":"13","author":"McCracken","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coi.2019.02.001_bib0230","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15674","article-title":"Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus","volume":"8","author":"Pantoja","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2019.02.001_bib0235","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3201\/eid2305.161630","article-title":"Lack of durable cross-neutralizing antibodies against Zika virus from dengue virus infection","volume":"23","author":"Collins","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.coi.2019.02.001_bib0240","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/infdis\/jiy164","article-title":"Longitudinal analysis of antibody cross-neutralization following Zika and dengue virus infection in Asia and the Americas","volume":"218","author":"Montoya","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2019.02.001_bib0245","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nm887","article-title":"Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever","volume":"9","author":"Mongkolsapaya","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2019.02.001_bib0250","doi-asserted-by":"crossref","first-page":"16922","DOI":"10.1073\/pnas.1010867107","article-title":"Immunodominant T-cell responses to dengue virus NS3 are associated with DHF","volume":"107","author":"Duangchinda","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2019.02.001_bib0255","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/infdis\/jiv289","article-title":"Human CD8+ T-cell responses against the 4 dengue virus serotypes are associated with distinct patterns of protein targets","volume":"212","author":"Weiskopf","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2019.02.001_bib0260","doi-asserted-by":"crossref","first-page":"E4256","DOI":"10.1073\/pnas.1505956112","article-title":"Dengue virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T cells associated with protective immunity","volume":"112","author":"Weiskopf","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2019.02.001_bib0265","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal5088","article-title":"Increased adaptive immune responses and proper feedback regulation protect against clinical dengue","volume":"9","author":"Simon-Loriere","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2019.02.001_bib0270","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa0526","article-title":"Virus-specific T lymphocytes home to the skin during natural dengue infection","volume":"7","author":"Rivino","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2019.02.001_bib0275","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ebiom.2016.10.006","article-title":"Protective role of cross-reactive CD8 T cells against dengue virus infection","volume":"13","author":"Elong Ngono","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.coi.2019.02.001_bib0280","doi-asserted-by":"crossref","first-page":"6494","DOI":"10.1128\/JVI.00036-15","article-title":"CD8+ T cells can mediate short-term protection against heterotypic dengue virus reinfection in mice","volume":"89","author":"Zellweger","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2019.02.001_bib0285","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.4049\/jimmunol.1401597","article-title":"CD8+ T cells prevent antigen-induced antibody-dependent enhancement of dengue disease in mice","volume":"193","author":"Zellweger","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2019.02.001_bib0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003723","article-title":"Role of humoral versus cellular responses induced by a protective dengue vaccine candidate","volume":"9","author":"Zellweger","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coi.2019.02.001_bib0295","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.94500","article-title":"Dengue vaccine-induced CD8+ T cell immunity confers protection in the context of enhancing, interfering maternal antibodies","volume":"2","author":"Lam","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.coi.2019.02.001_bib0300","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1016\/j.vaccine.2008.08.019","article-title":"Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects","volume":"26","author":"Guy","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2019.02.001_bib0305","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.4161\/hv.25562","article-title":"Persistence of Th1\/Tc1 responses one year after tetravalent dengue vaccination in adults and adolescents in Singapore","volume":"9","author":"Harenberg","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.coi.2019.02.001_sbref0310","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01469-17","article-title":"Prior dengue virus exposure shapes T cell immunity to Zika virus in humans","volume":"91","author":"Grifoni","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2019.02.001_bib0315","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.3389\/fimmu.2018.02225","article-title":"Cross-reactivity and anti-viral function of dengue capsid and NS3-specific memory T cells toward Zika virus","volume":"9","author":"Lim","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2019.02.001_bib0320","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01992-17","article-title":"Sustained specific and cross-reactive T cell responses to Zika and dengue virus NS3 in West Africa","volume":"92","author":"Herrera","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2019.02.001_bib0325","doi-asserted-by":"crossref","first-page":"274","DOI":"10.20411\/pai.v2i2.188","article-title":"T-cell responses in individuals infected with Zika virus and in those vaccinated against dengue virus","volume":"2","author":"Paquin-Proulx","year":"2017","journal-title":"Pathog Immun"},{"key":"10.1016\/j.coi.2019.02.001_sbref0330","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01669-z","article-title":"Dengue virus-reactive CD8(+) T cells mediate cross-protection against subsequent Zika virus challenge","volume":"8","author":"Wen","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2019.02.001_bib0335","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05458-0","article-title":"Cross-reactive dengue virus-specific CD8+ T cells protect against Zika virus during pregnancy","volume":"9","author":"Regla-Nava","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2019.02.001_bib0340","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10901-1","article-title":"Prior exposure to Zika virus significantly enhances peak dengue-2 viremia in rhesus macaques","volume":"7","author":"George","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2019.02.001_bib0345","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.cell.2017.02.017","article-title":"Modified mRNA vaccines protect against Zika virus infection","volume":"168","author":"Richner","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.coi.2019.02.001_sbref0350","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00900-17","article-title":"CD8(+) T cell immune response in immunocompetent mice during Zika virus infection","volume":"91","author":"Huang","year":"2017","journal-title":"J Virol"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791518301274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791518301274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:34:23Z","timestamp":1760603663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791518301274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":70,"alternative-id":["S0952791518301274"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2019.02.001","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antigenic cross-reactivity between Zika and dengue viruses: is it time to develop a universal vaccine?","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2019.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}